Study: Popular diabetes treatment is not associated with thyroid cancer

Concerns raised about an association between GLP-1 analogues, used to treat diabetes and obesity, and an increased risk of thyroid cancer are not supported by an extensive Scandinavian study.
GLP-1 analogues, such as Ozempic, lower blood sugar levels, slow stomach digestion, and suppress appetite. However, some previous studies and side effect data have indicated that the drugs may be linked to an increased risk of thyroid tumours.

Researchers at the Karolinska Institute, among others, have now investigated the matter by analysing nati...
Få tillgång till hela artikeln - enkelt och snabbt
Skapa en provprenumeration
Prova nu
Välj mellan våra prenumerationer på Life Science Sweden och hitta vad som passar dig och/eller ditt företag
Se prenumerationer
Utvalda artiklar


Sänd till en kollega